Encompass Health Corporation $EHC Shares Bought by Intech Investment Management LLC

Intech Investment Management LLC raised its stake in Encompass Health Corporation (NYSE:EHC) by 505.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 132,225 shares of the company’s stock after acquiring an additional 110,393 shares during the quarter. Intech Investment Management LLC’s holdings in Encompass Health were worth $14,034,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. WPG Advisers LLC lifted its holdings in Encompass Health by 73.3% in the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after acquiring an additional 137 shares during the period. Westside Investment Management Inc. raised its stake in shares of Encompass Health by 56.7% during the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after buying an additional 101 shares during the period. Flagship Harbor Advisors LLC acquired a new position in shares of Encompass Health during the 4th quarter worth approximately $37,000. Assetmark Inc. raised its stake in shares of Encompass Health by 88.1% during the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after buying an additional 140 shares during the period. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after buying an additional 362 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Up 0.6%

Shares of EHC opened at $105.98 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The stock has a market capitalization of $10.51 billion, a price-to-earnings ratio of 17.69, a PEG ratio of 2.30 and a beta of 0.72. The stock has a 50 day moving average price of $103.31 and a 200 day moving average price of $105.44.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. During the same period in the previous year, the business earned $1.37 earnings per share. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities research analysts forecast that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health’s payout ratio is presently 12.69%.

Wall Street Analysts Forecast Growth

EHC has been the subject of several research analyst reports. Leerink Partners set a $152.00 target price on Encompass Health in a research note on Friday, May 22nd. TD Cowen initiated coverage on Encompass Health in a research note on Thursday. They set a “buy” rating and a $125.00 target price for the company. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Barclays reduced their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $142.75.

Insider Activity at Encompass Health

In related news, Treasurer Edmund Fay sold 11,937 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the sale, the treasurer directly owned 89,325 shares in the company, valued at approximately $9,557,775. The trade was a 11.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Patrick William Tuer sold 682 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president owned 24,755 shares of the company’s stock, valued at $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by insiders.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.